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ABSTRACT  
Child behaviour management is crucial to successful treatment of atopic dermatitis. This study 
tested relationships between parents’ self-efficacy, outcome expectations, and self-reported task 
performance when caring for a child with atopic dermatitis. Using a cross-sectional study design, a 
community-based convenience sample of 120 parents participated in pilot-testing of the Child 
Eczema Management Questionnaire - a self-administered questionnaire which appraises parents’ 
self-efficacy, outcome expectations, and self-reported task performance when managing atopic 
dermatitis. Overall, parents’ self-reported confidence and success with performing routine 
management tasks was greater than that for managing their child’s symptoms and behaviour. There 
was a positive relationship between time since diagnosis and self-reported performance of routine 
management tasks; however, success with managing the child’s symptoms and behaviour did not 
improve with illness duration. Longer time since diagnosis was also associated with more positive 
outcome expectations of performing tasks that involved others in the child’s care (i.e. healthcare 
professionals, or the child themselves). This study provides the foundation for further research 
examining relationships between child, parent, and family psychosocial variables, parent 
management of atopic dermatitis, and child health outcomes. Improved understanding of these 
relationships will assist healthcare providers to better support parents and families caring for 
children with atopic dermatitis. 
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WHAT IS KNOWN ABOUT THIS TOPIC 
 Parents’ self-efficacy for managing children’s health treatments impacts child morbidity, but 
evaluation of parents’ self-efficacy in the context of AD management is limited. 
WHAT THIS PAPER ADDS 
 This paper provides important insights into the way in which parents of children with AD 
manage treatments and child behaviour problems. Parents in the study reported high levels 
of self-efficacy and success when performing routine AD management tasks. At the same 
time, they reported poorer self-efficacy and were less successful in managing their child’s 
symptoms and behaviour. Chronicity of AD was associated with better confidence and 
success in performing routine management tasks, but not in managing the child’s symptoms 
and behaviour. Results point to the potential importance of interventions to promote child 
behaviour and address parenting issues relevant to child AD management. 
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INTRODUCTION AND BACKGROUND 
Atopic dermatitis (AD), or “atopic eczema”, affects 17.5% of children worldwide1. 
International Study of Asthma and Allergies in Childhood (ISAAC) data indicate that 
prevalence has increased steadily in many countries over past decades, and prevalence in 
Australian and New Zealand children remains among the highest in the world1, 2. Australia 
has experienced one of the steepest increases in prevalence of severe AD, with a 185% 
relative increase between 1993 and 20031.  
     Characterised by dry skin, intense pruritis, and a papular rash which becomes excoriated 
and lichenified, onset occurs by age one in 60% of cases3, and 70 to 95% of affected 
individuals develop symptoms by age five4. Although presentation and distribution of lesions 
vary with age, the characteristically intense pruritis is the major cause of morbidity. 
Management strategies aim to control symptoms and prevent exacerbations, thereby reducing 
pruritis, minimising sleep disruption, and limiting the overall impact on child, parent, and 
family5. 
     Parents are instrumental to successful management in children. Unfortunately, the episodic 
and often unpredictable nature of AD can have a profoundly negative impact on the physical, 
psychological and social wellbeing of affected children and families6. Management can be 
time-consuming and costly, placing substantial financial burdens on families and the public 
health system7, and poorly controlled disease increases the risk of infection of affected skin 
by bacterial or viral agents8, contributing to the need for hospitalisation. 
     As may be expected, parents report a lack of confidence for managing AD9. This is not 
surprising given the reported levels of emotional, psychosocial, and behavioural difficulties 
experienced by children suffering a chronic illness generally10-13. Family environment, illness 
severity and chronicity of the disease rather than the specific illness place affected children at 
risk for adjustment disorders14-16. 
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    Management of AD may be made even more challenging by the child’s lack of co-
operation with management strategies, which can make providing treatment distressing for 
both child and parent17. This was the focus of previously reported research that indicated that 
not only infants18, 19, but also young children20 and even older children21-23 with AD were at 
increased risk of emotional and behavioural difficulties. Parents of children with AD were 
indeed found to be at higher risk of parenting stress, depression, and anxiety19, 20, 24. 
Dysfunctional family patterns and strain on parental relationships are common18, 20, 25. 
Increased family stress is associated with greater disease severity21, 26, increased likelihood of 
disease onset27, and reduced likelihood of disease resolution28. Dysfunctional family patterns 
can limit the family’s problem-solving and coping ability, exacerbating family tensions and 
triggering emotional reactions in the child, which may exacerbate atopic disease28. Less 
supportive family environments and greater impact of AD on family functioning have also 
been associated with behaviour problems in affected children21. 
     The concept of self-efficacy was first proposed by Bandura in 1977, and is a construct 
common to many health behaviour theories. In his seminal work, Bandura defined efficacy 
expectation as “the conviction that one can successfully execute the behaviour required to 
produce the outcomes”29. He proposed that, given adequate skills and incentives, an 
individual’s reaction to obstacles and adversity in a given situation – the amount of effort they 
will apply, and their level of perseverance – will be determined by their self-efficacy beliefs29. 
Over past decades, relationships have been identified between psychosocial factors and 
variations in parental self-efficacy – a parent’s perception of their own ability to perform tasks 
related to parenting their child30. Parents’ perceptions of child behaviour problems31, 32 and 
difficult child temperament33, 34 are associated with lower parental self-efficacy, as are 
parental depression33, 35 and stress 31. Conversely, social and marital support are associated 
with greater parental self-efficacy33, 36, and supportive marital relationships appear to bolster 
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parental efficacy37, reducing the impact of stressors38. Higher household income31, 34 and more 
years of formal education34 are also associated with greater parenting self-efficacy. Bandura37 
suggests that self-efficacy mediates the impact of multiple role-demands on parents’ 
wellbeing, although parents’ psychological state may also feedback directly to their self-
efficacy perceptions39. 
    Most importantly, parental self-efficacy appears to mediate actual parenting behaviour. 
Greater self-efficacy is associated with more positive parent-child interactions40, greater 
maternal competence33, 38, use of consistent discipline practices41, and parental warmth42. 
Moreover, emerging research reveals that parents’ self-efficacy predicts performance of 
management tasks when caring for a child with a chronic health condition, for example 
asthma43-46 and cystic fibrosis47. Furthermore, parents’ self-efficacy for managing their child’s 
condition has been associated with indicators of morbidity in children with asthma48, 49 and 
juvenile rheumatoid arthritis50, 51. Likewise, outcome expectations – expectations that the 
performance of certain behaviours will lead to particular outcomes52 – have been found to 
predict parents’ performance of asthma management tasks43-45 and asthma morbidity in 
children48, 53, 54. Despite the importance of these constructs to chronic disease management 
and health outcomes, self-efficacy, outcome expectations, and management behaviours of 
parents caring for children with AD remain virtually unexplored. 
     While interventions aiming to improve management of AD through psychological support 
and education of parents and caregivers are promising55-58, evaluations of effectiveness have 
been hampered by lack of sensitive, parent-focused instruments to measure change59. The 
Child Eczema Management Questionnaire (CEMQ)60 was developed as a measure of parents’ 
self-efficacy beliefs, outcome expectations, and self-reported task performance in the context 
of child AD management. The preliminary psychometric evaluation of the CEMQ is reported 
elsewhere60 (no identical material is included in this report). The current paper presents 
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descriptive data from pilot testing of the CEMQ, and provides a brief initial exploration of 
parents’ beliefs and behaviours in the context of child AD management.  
METHODS 
Sample and setting 
The sample was recruited nationally from all states of Australia except Queensland, which 
was excluded to prevent contamination of the pool of potential participants for a related study. 
Notices were placed in school newsletters in February 2009 inviting eligible parents to 
participate by completing a questionnaire, either online or in a printed format. Respondents 
returned completed questionnaires during February and March 2009. Participants met the 
following inclusion criteria: (a) is a primary caregiver of a child with AD aged 12 years or 
under; (b) child has a medical diagnosis of AD as reported by the parent; (c) gives informed 
consent to participate in the study. 
Measures 
The Child Eczema Management Questionnaire (CEMQ)60 evaluates a parent’s self-efficacy, 
outcome expectations, and self-reported task performance when managing their child’s AD. It 
contains three scales: (i) the modified Parent Self-Efficacy with Eczema Care Index 
(PASECI), (ii) the Parent Eczema Management Scale (PEMS), and (iii) the Parent Outcome 
Expectations of Eczema Management Scale (POEEMS). Each contains 25 items representing 
key AD management tasks, and respondents rate each item using 11-point Likert scales. Total 
scores for scales and subscales are generated by summing scores from each item and dividing 
by the number of items, and range from 0-10. Higher scores indicate greater self-efficacy, 
more successful task performance, and more positive outcome expectations.   
     First, the modified PASECI, derived from the original version of the Parental Self-Efficacy 
with Eczema Care Index61, was used to assess parents’ self-efficacy for managing various 
aspects of their child’s AD. Respondents rate their self-efficacy for performing each task from 
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0 (cannot do at all) to 10 (highly certain can do). PASECI has demonstrated satisfactory test-
retest reliability (r=.82) and internal consistency (α=.89) for the total scale, as well as for 
subscales Performing Routine AD Management Tasks (α=.84) and Managing the Child’s 
Symptoms and Behaviour (α=.85)60. 
     Next, PEMS was used to assess parents’ self-reported performance of AD management 
tasks. An indication of how often each task is successfully performed by the respondent is 
given by rating each from 0 (never) to 10 (always). PEMS has demonstrated satisfactory test-
retest reliability (r=.88) and good internal consistency for subscales Performing Routine AD 
Management Tasks (α=.88) and Managing the Child’s Symptoms and Behaviour (α=.83), and 
for the total scale (α=.90)60. 
     Lastly, POEEMS was used to appraise parents’ expectations that performing key 
management tasks would improve their child’s AD. The scale contains three subscales: 
Managing AD Myself (α=.87), Involving Healthcare Professionals (α=.86) and Involving My 
Child (α=.84). Each task is rated from 0 (not at all helpful) to 10 (always helpful). POEEMS 
has demonstrated good test-retest reliability (r=.89) and internal consistency for the subscales 
and for the total scale (α=.91)60. 
     Managing Personal Challenges when Caring for Your Child with Eczema is a subscale of 
the original version of PASECI, developed by Ersser et al.61. It contains 11 items that 
represent general obstacles to successful AD management, and is used to assess parents’ self-
efficacy for managing their child’s AD under challenging circumstances – for example, 
during or after experiencing personal or family problems. For the purposes of this study an 
additional item was added: “When my child is uncooperative with his/her treatment”. 
Respondents rate each item on an 11-point Likert scale response format anchored at 0 (cannot 
do at all) and 10 (highly certain can do), and item scores are averaged to provide a total score 
between 0 and 10. The subscale demonstrated good internal consistency (α=.93) and test-
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retest reliability (r=.92) in the present study. 
Statistical analyses 
Analyses were performed using SPSS 17.0. Descriptive statistics summarised sample 
characteristics. Frequency distributions of all variables were examined to determine 
distribution of data. Parametric tests were used for normally distributed data, and non-
parametric tests were used for data that was not normally distributed. A significance level of 
.05 was used to indicate statistically significant associations. 
RESULTS 
A total of 120 parents participated in the study. Sample characteristics are described in Table 
1. All children (aged 1-12 years) had been formally diagnosed with AD by at least one 
medical practitioner (general practitioner, dermatologist, or immunologist) for one year or 
longer. A chi-square goodness-of-fit test confirmed representativeness of the sample. No 
significant difference was found for the distribution of children from metropolitan (63.3%), 
regional or remote (36.7%) areas compared with 2006 Australian census population 
distribution data62, χ2 (1,n=120)=1.20, p=.273. The proportion of respondents from each 
participating state in Australia was also similar to the 2006 Australian population 
distribution63, χ2 (6,n=120)=8.46, p=.206. Most (94%, 113) chose to complete the online 
version of the questionnaire. 
Parents’ self-efficacy, task performance, and outcome expectations when managing AD 
Average scores for items and scale totals are presented in Table 2. Parents reported lowest 
self-efficacy for managing scratching behaviour and managing to avoid irritants. These tasks 
were also among those parents reported performing least successfully, along with helping 
their child to get involved in managing their AD, getting their child to follow their 
management plan when reluctant, and telling the GP when they disagree with them. In 
contrast, parents scored their outcome expectations of the majority of management tasks quite 
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highly (>8) on average, although they considered applying antibiotic cream was least likely to 
improve their child’s AD.    
     For the PASECI subscales, the median score for Performing Routine Management Tasks 
(8.77, range 4.60-10.00) was higher than for Managing the Child’s Symptoms and Behaviour 
(7.45, range 2.90-10.00). Similarly for PEMS, the median score for Performing Routine 
Management Tasks (7.81, range 1.63-10.00) was higher than for Managing the Child’s 
Symptoms and Behaviour (6.94, range 2.33-10.00). These differences were significant for 
both PASECI (Wilcoxon Signed Rank Test, z=6.85, p<.001) and PEMS (z=3.73, p<.001). 
Thus, parents rated themselves as more confident and successful in performing tasks related 
to routine management, and less confident and successful in managing their child’s symptoms 
and behaviour.  
     For the POEEMS subscales, the median score was highest for Involving My Child (9.00, 
range 0.00-10.00), followed by Managing AD Myself (8.50, range 2.79-10.00), and Involving 
Healthcare Professionals (8.39, range 1.44-10.00). Parents therefore rated tasks that involved 
the child participating in their own care as most likely to improve the child’s AD, followed by 
those tasks parents performed independently. The subscale of tasks related to involving 
healthcare professionals in the child’s management was rated least likely to improve the 
child’s condition. A Friedman test revealed that differences across subscale scores for 
POEEMS were also statistically significant, χ2 (2,n=120)=10.63, p=.005.  
     There were positive relationships between duration of AD and total scores for PEMS 
(r=.24, n=120, p=.008) and POEEMS (r=.23, n=120, p=.013). Longer duration was associated 
with more successful task performance, and more positive outcome expectations of 
performing management tasks. For PEMS, longer duration of AD was associated with greater 
self-reported success in Performing Routine Management Tasks (rho=.24, n=120, p=.007); 
however, there was no significant relationship between AD duration and success in Managing 
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the Child’s Symptoms and Behaviour (rho=.12, n=120, p=.210). For POEEMS, longer 
duration of AD was associated with more positive outcome expectations of both Involving 
Healthcare Professionals (rho=.19, n=120, p=.035) and Involving My Child (rho=.19, n=120, 
p=.035); however, there was no significant relationship between duration of AD and outcome 
expectations of Managing AD Myself (rho=.12, n=120, p=.210).  
     There was no significant relationship between AD duration and scores for PASECI (r=.15, 
n=120, p=.104); nor were there significant relationships between self-efficacy, task 
performance, or outcome expectations and the age of the parent or child, or gender of the 
child. 
Managing personal challenges when caring for a child with AD 
The mean score for Managing Personal Challenges when Caring for Your Child with Eczema 
was 7.19 (SD=1.81). Median scores for all 11 items fell between 7 and 8 (potential range for 
subscale: 0-10). On average, parents reported feeling least confident in managing their child’s 
AD (i) when they were feeling ill themselves, (ii) when their child was uncooperative with 
his/her treatment, (iii) when it was difficult to get the prescribed creams, or (iv) when they 
themselves were feeling low or anxious (see Figure 1).  
DISCUSSION 
To facilitate development and evaluation of evidence-based, parent-focused interventions to 
improve management of childhood AD, reliable and valid instruments to appraise parents’ 
self-efficacy, outcome expectations, and performance of AD management tasks are needed. 
This paper presents one of the first examinations of self-efficacy beliefs, outcome 
expectations, and self-reported performance of management tasks by parents caring for a child 
with AD. Together, the scales comprising the CEMQ provide the opportunity to examine all 
three key constructs of self-efficacy theory, as defined by Bandura, in the context of child AD 
management. This has been neglected by researchers to date whose focus has been self-
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efficacy alone. 
      As previously reported60, factor analysis of PASECI and PEMS revealed the presence of a 
common factor referring to management of symptoms and behaviour. Interestingly, parents 
reported greater self-efficacy and success when performing routine AD management tasks, 
and lower self-efficacy and less success when managing their child’s symptoms and 
behaviour. Furthermore, longer duration of AD was associated with increased confidence and 
success in performing routine management tasks, but not in managing symptoms and 
behaviour. This is important considering the documented difficulties faced by this clinical 
group with regard to child behaviour problems, and parental stress, anxiety, and depression. 
Within the literature, parents have reported feelings of distress or incompetence in relation to 
parenting children with AD, particularly with managing problem behaviours20, 24, and may be 
reluctant to discipline their child in an attempt to avoid conflict, or because they may “feel 
sorry” for them20. As previously described, there are relationships between child behaviour 
problems and difficulty with managing child chronic health conditions. Moreover, emerging 
research has identified a relationship between parents’ self-efficacy for performing key 
asthma management tasks and self-efficacy for managing problem behaviours of children 
with asthma64. Overall, results suggest that greater attention needs to be paid to parents’ needs 
for support in managing symptoms and behaviour related to AD. 
     Lack of agreement between parents and healthcare professionals regarding AD treatment 
and management goals is common65, and contributes non-adherence, sub-optimal 
management, and worse child health outcomes66. In the present study, parents rated tasks 
involving healthcare professionals (e.g. “Tell the GP when you disagree with him/her”) as 
least likely to improve their child’s AD, and parents of more recently diagnosed children 
reported less positive expectations of involving healthcare professionals in AD management 
compared to parents who had been managing their child for longer. Caution should be 
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exercised when interpreting these results due to relatively weak relationships between the 
variables; however, this is a potentially important finding considering the well-established 
relationship between outcome expectations and task performance52. On this basis, it is 
plausible that a parent who expects less positive outcomes from involving healthcare 
professionals in their child’s care may be less likely to actively seek advice and assistance 
when problems arise.     Finally, parents reported that self-efficacy for managing AD was 
lowest when they were feeling anxious or low, or when their child was uncooperative with 
treatment. These findings are also significant considering the elevated rates of depression and 
child behaviour difficulties reported for this clinical group in current literature. 
     Overall, results from this study reveal the potential importance of child behaviour and 
parenting issues to child AD management, and confirm the need for a detailed exploration of 
relationships between child, parent, and family factors, and parents’ self-efficacy, outcome 
expectations, performance of AD management tasks, and child health outcomes. In particular, 
attention should focus on the possible impact of child behaviour difficulties on parents’ self-
efficacy in the context of child AD management. Although parents reported lower confidence 
and less success with managing their child’s symptoms and behaviour, little is known about 
parents’ perceptions of the challenges to successful management posed by child behaviour 
difficulties. Future research should explore parents’ perceptions of key behavioural issues that 
impact their self-efficacy and ability to successfully manage their child’s condition. 
Moreover, efforts should be made to include direct observations of child behaviour and parent 
performance of AD management tasks to confirm the validity of PEMS, and enable 
assessment of relationships between parents’ self-efficacy, outcome expectations, and 
observed behaviour in this context. 
Limitations 
While a relatively small convenience sample of respondents self-selected for participation in 
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the study, and data on socioeconomic status was not collected, the sample was representative 
on the basis of geographical spread. Further exploration of these constructs should aim to 
include samples of objectively-assessed clinical severity and socioeconomic diversity. 
CONCLUSION AND IMPLICATIONS FOR CLINICAL PRACTICE 
These findings represent a brief preliminary exploration of beliefs and behaviours of parents 
caring for children with AD. As paediatric and child health nurses, it is imperative to consider 
the psychosocial context when caring for children with chronic health conditions, recognising 
situations which may impact on parents’ confidence and/or ability to implement treatment 
plans and successfully manage their child’s condition. The CEMQ has potential to be useful 
in clinical settings to assess strengths, limitations, and concerns of parents when managing 
their child’s AD. Its use may facilitate discussion between families and the clinicians caring 
for them, and enable clinicians to plan interventions to target specific areas of concern to the 
parent – for example, applying topical medications correctly, managing child behaviour, or 
communicating with healthcare professionals. Moreover, the instrument has potential utility 
in evaluation of interventions targeting parents’ self-efficacy, outcome expectations, and task 
performance when managing their child’s AD. This study provides the foundation for further 
research examining relationships between child, parent, and family psychosocial variables, 
parent management of AD, and child health outcomes. Ultimately, greater understanding of 
relationships between these variables will assist healthcare providers to better support parents 
and families caring for children with AD.  
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Table 1. Characteristics of Study Participants (N=120)  
Variable  
 
Parent age (years) 
Child age (years) 
Parent gender % (no.) 
    Male 
    Female  
Child gender % (no.) 
    Male      
    Female  
Duration of child’s AD (years) 
 
           37.86 (5.79) 
             6.68 (2.94) 
 
             5.0 (6) 
           95.0 (114) 
          
  45.8 (55) 
  54.2 (65) 
             5.72 (2.86) 
Note. All figures are means (SD) unless stated otherwise. 
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Table 2. Average scores for PASECI, PEMS, and POEEMS items and total scores (N=120)  
 PASECI 
 
PEMS 
 
POEEMS 
 
Items 
1. Choose a moisturiser 
2. Apply moisturisers 
3. Apply antibiotic creams 
4. Correctly use steroid creams 
5. Apply dressings/bandages 
6. Make right choice of treatment options if eczema becomes worse 
7. Take appropriate action if you thing eczema infected 
8. Judge whether the treatments/medications works 
9. Ask a GP if you want to change medications 
10. Ask a specialist if you want to change medications 
11. Manage your child’s scratching behaviour 
12. Help child to get involved in managing eczema 
13. Get child to follow management plan when reluctant 
14. Help child fit eczema into a normal lifestyle 
15. Manage to avoid things that irritate/aggravate eczema 
16. Adjust management plan to allow for changes in schedule 
17. Control eczema so child can play like other children 
18. Manage eczema so symptoms are under control 
19. Reduce sleep disturbance 
20. Get access to healthcare professional 
21. Tell GP when eczema not getting better 
22. Ask GP to explain when don’t understand 
23. Tell GP when disagree  
24. Decide when to call in help from GP or nurse 
25. Ask to see a specialist 
 
Scale total – mean (SD) 
 
9 (1-10)  
10 (1-10) 
10 (0-10) 
10 (0-10) 
10 (0-10) 
8 (0-10) 
9 (0-10) 
9 (2-10) 
10 (0-10) 
10 (0-10) 
6 (0-10) 
8 (0-10) 
8 (0-10) 
8 (0-10) 
7 (0-10) 
8 (0-10) 
9 (2-10) 
8 (0-10) 
8 (0-10) 
9 (0-10) 
10 (1-10) 
10 (2-10) 
8 (0-10) 
10 (0-10) 
10 (0-10) 
 
8.12 (1.19) 
 
8 (0-10) 
9 (0-10) 
8 (0-10) 
9 (0-10) 
8 (0-10) 
8 (0-10) 
9 (0-10) 
9 (0-10) 
8 (0-10) 
8 (0-10) 
6 (0-10) 
7 (0-10) 
7 (0-10) 
8 (0-10) 
7 (0-10) 
8 (0-10) 
8 (2-10) 
8 (0-10) 
8 (0-10) 
8 (0-10) 
9 (0-10) 
9 (0-10) 
7 (0-10) 
9 (0-10) 
9 (0-10) 
 
7.19 (1.81) 
 
9 (1-10) 
9 (0-10) 
8 (0-10) 
9 (0-10) 
9 (0-10) 
9 (2-10) 
10 (0-10) 
9 (2-10) 
9 (0-10) 
9 (0-10) 
9 (0-10) 
9 (0-10) 
9 (0-10) 
9 (0-10) 
9 (0-10) 
9 (0-10) 
10 (0-10) 
9 (0-10) 
9 (0-10) 
9 (0-10) 
10 (0-10) 
10 (0-10) 
9 (0-10) 
9 (0-10) 
10 (0-10) 
 
8.07 (1.48) 
Note. Figures represent median (min-max) unless stated otherwise. Range of scores for items and scale totals = 0–10. 
PASECI: Parent Self-Efficacy with Eczema Care Index; PEMS: Parent Eczema Management Scale; POEEMS: Parent 
Outcome Expectations of Eczema Management Scale.  
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Table 3. “Managing Personal Challenges When Caring for Your Child with 
Eczema” items ranked by median score (N=120)  
Item Average score 
When I am feeling ill 
When my child is uncooperative with his/her treatment 
When it’s difficult to get the prescribed creams 
When I am feeling low or anxious 
During or after experiencing personal or family problems 
When I am tired 
When it’s difficult to get the right clothes for my child 
When I have other time commitments 
When I am feeling under pressure from work 
Without support from my family or friends 
During a holiday 
When I have too much housework/childcare to do at home 
7 (0-10) 
7 (0-10) 
7 (0-10) 
7 (0-10) 
8 (0-10) 
8 (0-10) 
8 (0-10) 
8 (1-10) 
8 (0-10) 
8 (0-10) 
8 (1-10) 
8 (1-10) 
Note. Figures represent median (min-max). Possible range of scores for items = 0–10  
 
 
 
 Figure 1. Box-and-whisker plot of responses to items: “Managing Personal Challenges When Caring for 
Your Child with Eczema” 
 
Note. Boxes represent interquartile range with median. Response scale: 0 = cannot do at all, 10 = certain can do. 
 
 
 
 
